AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)
CUSIP: 03152W109
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 312,579,912
- Total 13F shares
- 276,914,599
- Share change
- +959,279
- Total reported value
- $2,669,802,857
- Put/Call ratio
- 33%
- Price per share
- $9.64
- Number of holders
- 222
- Value change
- +$6,810,492
- Number of buys
- 112
- Number of sells
- 113
Quarterly Holders Quick Answers
What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03152W109:
Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
7.8%
|
24,387,053
|
$240,945,000 | — | 31 Mar 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
7.3%
|
22,861,329
|
$225,870,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.9%
|
21,521,879
|
$212,636,000 | — | 31 Mar 2021 | |
| Redmile Group, LLC |
13F
|
Company |
6.8%
|
21,114,114
|
$208,607,000 | — | 31 Mar 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4.5%
|
14,107,972
|
$139,386,000 | — | 31 Mar 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
3.9%
|
12,250,000
|
$121,030,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.8%
|
11,879,824
|
$117,373,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
3.2%
|
9,966,548
|
$98,470,000 | — | 31 Mar 2021 | |
| Palo Alto Investors LP |
13F
|
Company |
3.1%
|
9,761,043
|
$96,439,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
3.1%
|
9,536,942
|
$94,225,000 | — | 31 Mar 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.9%
|
8,984,055
|
$88,762,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
2.3%
|
7,313,927
|
$72,261,000 | — | 31 Mar 2021 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.8%
|
5,733,479
|
$56,647,000 | — | 31 Mar 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.8%
|
5,694,195
|
$56,258,000 | — | 31 Mar 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.4%
|
4,414,976
|
$43,620,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
4,375,227
|
$43,227,000 | — | 31 Mar 2021 | |
| Artal Group S.A. |
13F
|
Company |
1.2%
|
3,750,000
|
$37,050,000 | — | 31 Mar 2021 | |
| Fiera Capital Corp |
13F
|
Company |
1%
|
3,206,490
|
$31,680,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.95%
|
2,960,716
|
$29,253,000 | — | 31 Mar 2021 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.93%
|
2,894,879
|
$28,601,000 | — | 31 Mar 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.86%
|
2,698,497
|
$26,661,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.75%
|
2,354,088
|
$23,258,000 | — | 31 Mar 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
0.74%
|
2,325,000
|
$22,971,000 | — | 31 Mar 2021 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.74%
|
2,305,432
|
$22,778,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.73%
|
2,282,406
|
$22,550,000 | — | 31 Mar 2021 | |
| NORGES BANK |
13F
|
Company |
0.7%
|
2,188,692
|
$21,624,000 | — | 31 Mar 2021 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.68%
|
2,130,000
|
$21,044,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.67%
|
2,085,672
|
$20,606,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.66%
|
2,064,552
|
$20,397,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.65%
|
2,020,527
|
$19,963,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.64%
|
2,011,327
|
$19,872,000 | — | 31 Mar 2021 | |
| Novo Holdings A/S |
13F
|
Company |
0.63%
|
1,962,880
|
$19,393,000 | — | 31 Mar 2021 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.6%
|
1,861,400
|
$18,391,000 | — | 31 Mar 2021 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.57%
|
1,766,704
|
$17,455,000 | — | 31 Mar 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
1,761,865
|
$17,407,000 | — | 31 Mar 2021 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.54%
|
1,692,241
|
$16,719,000 | — | 31 Mar 2021 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.52%
|
1,616,670
|
$16,263,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.5%
|
1,553,776
|
$15,351,000 | — | 31 Mar 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.2%
|
615,124
|
$13,643,000 | — | 31 Mar 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.4%
|
1,260,156
|
$12,450,000 | — | 31 Mar 2021 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
1,160,724
|
$11,468,000 | — | 31 Mar 2021 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.37%
|
1,145,594
|
$11,318,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.34%
|
1,047,164
|
$10,345,000 | — | 31 Mar 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.32%
|
1,012,506
|
$10,004,000 | — | 31 Mar 2021 | |
| Grosvenor Holdings, L.L.C. |
13F
|
Company |
0.31%
|
971,866
|
$9,602,000 | — | 31 Mar 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.31%
|
957,077
|
$9,456,000 | — | 31 Mar 2021 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.25%
|
791,367
|
$7,819,000 | — | 31 Mar 2021 | |
| Fairmount Funds Management LLC |
13F
|
Company |
0.25%
|
788,980
|
$7,795,000 | — | 31 Mar 2021 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.25%
|
779,323
|
$7,699,711 | — | 31 Mar 2021 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.23%
|
728,241
|
$7,195,000 | — | 31 Mar 2021 |
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2021
As of 30 Jun 2021,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
222 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
276,914,599 shares.
The largest 10 holders included
VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Redmile Group, LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, Avoro Capital Advisors LLC, MORGAN STANLEY, Palo Alto Investors LP, and STATE STREET CORP.
This page lists
222
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
241
Q2 2021 holders
222
Holder diff
-19
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.